Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059310) titled 'Multicenter International Collaborative Study on Establishing Standardized End-of-Life Care Methods for Cancer Patients' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To identify the most effective end-of-life care methods for managing symptoms in patients with cancer
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (1) Patients aged 18 years or older
(2) Cancer patients with locally advanced or metastatic disease diagnosed by histological, cytological, or clinical means
(3) Patients admitted to a palliative care unit or palliative care bed
Key exclusion criteria - (1) Patients scheduled for transfer or discharge
(2) Patients who have expressed refusal to participate in this study to the patient or family
(3) Patients deemed unsuitable for participation in this study by the attending physician
Target Size - 1000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 10 Month 07 Day
Date of IRB - 2025 Year 11 Month 20 Day
Anticipated trial start date - 2026 Year 01 Month 01 Day
Last follow-up date - 2027 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067825
Disclaimer: Curated by HT Syndication.
